Results 171 to 180 of about 365,681 (229)

Remarkable Response to Etoposide and Cisplatin in Aggressive-Variant Prostate Cancer With Low Prostate-Specific Antigen Levels: A Case Report. [PDF]

Cureus
Ikeda J, Taniguchi H, Inoue M, Masuo Y, Nakamoto T, Yanishi M, Uchida K, Kinoshita H.   +7 more
europepmc   +1 more source

Prediagnosis Prostate-Specific Antigen Testing History in Patients With Incident Prostate Cancer.

JAMA Netw Open
Guittet L, Denis P, Tuppin P, Fiard G, Mathieu R, De Bels F, Le Bihan C, Rachas A.   +7 more
europepmc   +1 more source

Prostate specific antigen retesting intervals and trends in England: population based cohort study. [PDF]

BMJ
Collins KK, Oke JL, Virdee PS, Perera R, Nicholson BD.   +4 more
europepmc   +1 more source

Diagnostic Value of Transabdominal Ultrasound-based Versus Magnetic Resonance Imaging-based Prostate-specific Antigen Density for Clinically Significant Prostate Cancer. [PDF]

Eur Urol Open Sci
Xu Z, Song H, Huang H, Fu M, Tang Y, Zhang P, Zhang G, Li J.   +7 more
europepmc   +1 more source

Salivary microbiome in patients with benign prostatic hyperplasia: altered composition and its association with prostate-specific antigen. [PDF]

BMC Microbiol
Zhang B, Guo H, Li Z, Lin H, Zhi J, Tang Y, Sun Y, Xia Q, Wang S, Jiang P, Gu C, Wei S, Zhao Y, Li Z, Guo W, Gu Y, Gao F, Liu F, Wu Y, Feng N, Xu Z, Chen W.   +21 more
europepmc   +1 more source

Prognostic Role of Prostate-Specific Antigen (PSA) in male patients hospitalized for COVID-19. [PDF]

Pak J Med Sci
Ceylan Y, Demir I, Calik S, Akan OY, Yoldas E.   +4 more
europepmc   +1 more source

Interchangeability and Diagnostic Accuracy of Two Assays for Total and Free Prostate-Specific Antigen: Two not Always Related Items

, 2007
Ruggero Dittadi, R. Franceschini, Antonio Fortunato, Matelda Zancan, M. Barichello, A. Tasca, Davide Giavarina, L. Peloso, Giuliano Soffiati, Massimo Gion   +9 more
openalex   +2 more sources

Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide. [PDF]

J Comp Eff Res
Lowentritt BH, Burbage S, Khilfeh I, Pilon D, Du S, Rossi C, Kinkead F, Diaz L, Brown G.   +8 more
europepmc   +1 more source

Identification of prostate cancer by urinary DLX1/HOXC6 expression in Chinese population with prostate-specific antigen levels of 4-10 ng/mL. [PDF]

Sci Rep
Zhang D, Xu J, Wang J, Jiang J.
europepmc   +1 more source

Association between red blood cell distribution width to albumin ratio and prostate specific antigen based on NHANES data. [PDF]

Am J Transl Res
Yang Z, Zhang M, Liu L, Qiu X, Shi Y, Li N, Ning H.   +6 more
europepmc   +1 more source